# Improving Tumor Oxygenation in Cervical Cancer

> **NCT00257829** · PHASE2 · WITHDRAWN · sponsor: **University of California, Irvine**

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Methazolamide
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00257829
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2004-07
- **Primary completion:** 2006-09-20
- **Final completion:** 2006-09-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was closed due to lack of funding.
- **Last updated:** 2018-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257829, "Improving Tumor Oxygenation in Cervical Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00257829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*